InvestorsHub Logo
Followers 827
Posts 18500
Boards Moderated 0
Alias Born 05/08/2007

Re: MASTERTRADER post# 831

Friday, 11/11/2011 4:09:03 PM

Friday, November 11, 2011 4:09:03 PM

Post# of 3720
Michael Cohen , President of the Company, stated: "The approval of the CIR and its issuance of an INCI name to our Matrix NC-138 is a significant and momentous occasion. We have now demonstrated that we are committed to develop and deliver to the market safe and innovative products. The issuance of the INCI name will allow the company to move forward with commercialization of our cosmeceutical product, Proteoderm NC-138 in the USA ."